Massachusetts General Hospital: Colorectal Neoplasms trials

The registry lists 29 Colorectal Neoplasms studies with Massachusetts General Hospital as lead sponsor. 7 are open to participants now and 10 have results posted.

Early Phase 1 2Phase 1 6Phase 2 9No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Mind-Body Sexual Well-Being Program for Female GI Cancer SurvivorsNot yet recruitingNCT07795801Not applicable
• Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer SurvivorsNot yet recruitingNCT07701707Not applicable
• BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer PreventionRecruitingNCT07162337Not applicable
• Botensilimab, Balstilimab, and SBRT in Colorectal CancerRecruitingNCT07128355Early Phase 1
• Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal TumorsRecruitingNCT07095517Phase 1
• COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCERRecruitingNCT05692024Phase 1/2
• Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot StudyRecruitingNCT05524428Not applicable
• Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer SurvivorsCompletedNCT06331403Not applicableResults posted
• Community Collaboration to Advance Racial/Ethnic Equity in CRC ScreeningCompletedNCT05714644Not applicableResults posted
• ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTensionActive, not recruitingNCT05056896Early Phase 1Results posted
• Virtual Health Insurance Navigation Pilot Program for Colorectal SurvivorsCompletedNCT05002608Not applicableResults posted
• PRevention Using EPA Against coloREctal CancerCompletedNCT04216251Phase 1/2Results posted
• Promoting Informed Decisions About Cancer Screening in Older AdultsCompletedNCT03959696Not applicableResults posted
• A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal CancerCompletedNCT03144804Phase 2Results posted
• ASPirin Intervention for the REDuction of Colorectal Cancer RiskActive, not recruitingNCT02394769Not applicableResults posted
• Pilot Study of GVAX in Colorectal Cancer CellsTerminatedNCT01952730Phase 1Results posted
• Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal CancerCompletedNCT00842257Phase 2Results posted
• Colonoscopy Screening: Setting Epic Follow-up TimesCompletedNCT05631873Not applicable
• Pressure-enabled Delivery in Radioembolization (TriNav Study)CompletedNCT05128032Not applicable
• Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
• Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
• Nivolumab+Ipilimumab+RT in MSS mCRCStatus unknownNCT04575922Phase 2
• Dabrafenib + Trametinib + PDR001 In Colorectal CancerStatus unknownNCT03668431Phase 2
• OMega-3 Fatty Acid for the Immune Modulation of Colorectal CancerWithdrawnNCT03661047Phase 2
• Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use DisorderCompletedNCT03244787Not applicable
• Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal CancerCompletedNCT03223779Phase 1/2
• Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health ITCompletedNCT01372527Not applicable
• Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking PopulationsCompletedNCT00476970Not applicable
• SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2